About Tenpoint Therapeutics
Tenpoint Therapeutics, Ltd is a global commercial ophthalmic pharmaceutical company with treatments for the aging eye.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Irvine, California
- Founded
- 2019
- Company type
- Privately Held
- Company profile name
- Tenpoint Therapeutics, Ltd.
This page is intended for US audiences only.
Tenpoint Therapeutics, Ltd. is a global commercial ophthalmic pharmaceutical company focused on the commercialization of YUVEZZI™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1%, the first and only dual-agent eye drop for the treatment of presbyopia, a condition that affects nearly 128 million people in the U.S. and approximately 2 billion people globally. By understanding real-world needs and partnering with eye care professionals, Tenpoint is working to bring innovation to the aging eye. Tenpoint Therapeutics’ leadership team includes ophthalmic industry luminaries with track records of successful approval and commercialization of blockbuster treatments.
Specialties
- Presbyopia
- Ophthalmology
- Optometry
- Eye Health
- Glaucoma
- macular degeneration
- dry eye disease
- AMD
- and ocular surface disease
Company locations
5151 California Ave, 200, Irvine, California 92617, US
2 Nickerson St, Suite 101, Seattle, Washington 98109, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
On LinkedIn
- Followers
- 11,855
- People linked to this company
- 131
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.